Maternal, Fetal, and Placental Selectins in Women With Pre-eclampsia; Association With the Renin-Angiotensin-System
Overview
Affiliations
Selectins [endothelial (E), platelet (P), and leucocytes (L)] are a class of cell adhesion molecules, stimulated in response to inflammation. Pre-eclampsia is characterized by inflammation, and angiotensin II is pro-inflammatory. We hypothesized that circulating maternal and fetal concentrations and placental expression of selectins would be increased in women with pre-eclampsia and would be associated with the angiotensin receptors (AT1R and AT2R). Maternal and fetal blood and placental tissue was collected at delivery from White European normotensive controls ( = 17) and women with pre-eclampsia ( = 17). Soluble (s) E-, P- and L-selectin protein concentrations were measured by ELISA and placental protein expression was examined by immunohistochemistry. Maternal sE-selectin concentrations were increased in pre-eclampsia ( < 0.001); conversely fetal sE- and sP-selectin levels were lower in pre-eclampsia ( < 0.05 for both). Staining was mainly localized to the syncytiotrophoblast for all selectins. E-selectin expression was increased, while P-selectin was decreased in placental from pre-eclampsia ( < 0.05 for both); no differences were observed for L-selectin expression. Both E- and L-selectin were positively correlated ( < 0.008; < 0.02) with AT2R placental expression, whilst P-selectin was negatively associated with AT1R ( < 0.005), all only in the pre-eclampsia group. This novel study reports maternal, fetal and placental expression of selectins in pre-eclampsia. The increased E-selectins reflect the endothelial dysfunction, characteristic of pre-eclampsia. In contrast, the reduced P-selectins and the positive association of placental AT2Rs with both E-and L-selectin in pre-eclampsia could be a protective mechanism to limit the endothelial dysfunction.
Sibiya S, Mlambo Z, Mthembu M, Mkhwanazi N, Naicker T Int J Mol Sci. 2024; 25(19).
PMID: 39409189 PMC: 11476673. DOI: 10.3390/ijms251910860.
Pathophysiology of Pre-Eclampsia-Two Theories of the Development of the Disease.
Kornacki J, Olejniczak O, Sibiak R, Gutaj P, Wender-Ozegowska E Int J Mol Sci. 2024; 25(1).
PMID: 38203478 PMC: 10779413. DOI: 10.3390/ijms25010307.
Raghu R, Kurlak L, Lee E, Mistry H Placenta. 2023; 134:9-14.
PMID: 36848863 PMC: 10682376. DOI: 10.1016/j.placenta.2023.02.006.
Diagnostic biomolecules and combination therapy for pre-eclampsia.
Qi J, Wu B, Chen X, Wei W, Yao X Reprod Biol Endocrinol. 2022; 20(1):136.
PMID: 36068569 PMC: 9446775. DOI: 10.1186/s12958-022-01003-3.
Endothelial Dysfunction in Pregnancy Complications.
Kornacki J, Gutaj P, Kalantarova A, Sibiak R, Jankowski M, Wender-Ozegowska E Biomedicines. 2021; 9(12).
PMID: 34944571 PMC: 8698592. DOI: 10.3390/biomedicines9121756.